过去一年中添加的文章，按日期排序
Exploring the Multifaceted Therapeutic Mechanism of Schisanlactone E (XTS) in APP/PS1 Mouse Model of Alzheimer's Disease through Multi-Omics Analysis
Z Song, J He, W Yu, C He, M Yang, P Li, Z Li… - Frontiers in … - frontiersin.org
11 天前 - … properties, yet the mechanisms of XTS's therapeutic effects on Alzheimer's disease
(AD) … 16S rDNA sequencing analyzed gut microbiota metabolic alterations, and metabolomic …
(AD) … 16S rDNA sequencing analyzed gut microbiota metabolic alterations, and metabolomic …
[HTML][HTML] Potential effects of the most prescribed drugs on the microbiota-gut-brain-axis: A review
K Garg, MH Mohajeri - Brain Research Bulletin, 2024 - Elsevier
173 天前 - … The report aims to explore whether drugs can influence … gut microbiota and
gut-brain axis with the respective … remain on the bacterial composition of the gastrointestinal …
gut-brain axis with the respective … remain on the bacterial composition of the gastrointestinal …
Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies
D Seo, DM Holtzman - Experimental & molecular medicine, 2024 - nature.com
188 天前 - … community of gut microbiota to alleviate disease progression. … ’ gut microbiota are
quite different, they may still exhibit similar … Recent studies have examined the gut microbiota …
quite different, they may still exhibit similar … Recent studies have examined the gut microbiota …
Role of Gut Microbiome, Alpha Synuclein in the Prodromal Stage of Parkinson Disease.
M Meglio - Neurology Live, 2023 - go.gale.com
289 天前 - … Second, we explore whether the gut can be a potential avenue for … in Alzheimer's
research. While Alpha synuclein biomarkers are not yet integrated into clinical practice, they …
research. While Alpha synuclein biomarkers are not yet integrated into clinical practice, they …